WOBURN, Mass.--(BUSINESS WIRE)--Courtagen Life Sciences, Inc., an innovative molecular information company, announced today the release of several new Next Generation Sequencing tests focused on expanding diagnostic options for physicians treating patients suffering from epilepsy and seizure disorders, and mitochondrial disease.
Help employers find you! Check out all the jobs and post your resume.
Help employers find you! Check out all the jobs and post your resume.
